Douglas Mccord Sammond

Archive Network Publication Hotspot Collaboration

Network

Latest external collaboration on country level. Dive into details by clicking on the dots.

Explore More

Hotspot

Dive into the research topics where Douglas Mccord Sammond is active.

Explore More

Publication

Featured researches published by Douglas Mccord Sammond.

Bioorganic & Medicinal Chemistry Letters | 2009

Synthesis and stereochemical effects of pyrrolidinyl-acetylenic thieno[3,2-d]pyrimidines as EGFR and ErbB-2 inhibitors.

Kirk L. Stevens; Krystal J. Alligood; Jennifer G. Badiang Alberti; Thomas R. Caferro; Stanley D. Chamberlain; Scott Howard Dickerson; Hamilton D. Dickson; Holly Kathleen Emerson; Robert J. Griffin; Robert D. Hubbard; Barry R. Keith; Robert J. Mullin; Kimberly G. Petrov; Roseanne M. Gerding; Michael J. Reno; Tara Renae Rheault; David W. Rusnak; Douglas Mccord Sammond; Stephon C. Smith; David E. Uehling; Alex G. Waterson; Edgar R. Wood

A novel class of pyrrolidinyl-acetyleneic thieno[3,2-d]pyrimidines has been identified which potently inhibit the EGFR and ErbB-2 receptor tyrosine kinases. Synthetic modifications of the pyrrolidine carbamate moiety result in a range of effects on enzyme and cellular potency. In addition, the impact of the absolute stereochemical configuration on cellular potency and oral mouse pharmacokinetics is described.

Archive | 2003

Diamino-pyrimidines and their use as angiogenesis inhibitors

Stanley D. Chamberlain; Mui Cheung; Holly Kathleen Emerson; Neil W. Johnson; Kristen E. Nailor; Douglas Mccord Sammond; Marcus Semones

Bioorganic & Medicinal Chemistry Letters | 2006

Ultra-potent P1 modified arylsulfonamide HIV protease inhibitors: The discovery of GW0385.

John F. Miller; C. Webster Andrews; Michael Stephen Brieger; Eric S. Furfine; Michael R. Hale; Mary H. Hanlon; Richard J. Hazen; Istvan Kaldor; Ed W. McLean; David J. Reynolds; Douglas Mccord Sammond; Andrew Spaltenstein; Roger D. Tung; Elizabeth M. Turner; Robert X. Xu; Ronald G. Sherrill

Bioorganic & Medicinal Chemistry Letters | 2005

Discovery of a novel and potent series of dianilinopyrimidineurea and urea isostere inhibitors of VEGFR2 tyrosine kinase

Douglas Mccord Sammond; Kristen E. Nailor; James M. Veal; Robert T. Nolte; Liping Wang; Victoria B. Knick; Sharon K. Rudolph; Anne T. Truesdale; Eldridge N. Nartey; Jeffrey A. Stafford; Rakesh Kumar; Mui Cheung

Bioorganic & Medicinal Chemistry Letters | 2009

Synthesis and evaluation of aniline headgroups for alkynyl thienopyrimidine dual EGFR/ErbB-2 kinase inhibitors

Alex G. Waterson; Kimberly G. Petrov; Keith R. Hornberger; Robert D. Hubbard; Douglas Mccord Sammond; Stephon C. Smith; Hamilton D. Dickson; Thomas R. Caferro; Kevin W. Hinkle; Kirk L. Stevens; Scott Howard Dickerson; David W. Rusnak; Glenn M. Spehar; Edgar R. Wood; Robert J. Griffin; David E. Uehling

Archive | 2005

Novel Diazepine Compounds as Ligands of the Melanocortin 1 and/or 4 Receptors

Jerzy Ryszard Szewczyk; Jason D. Speake; Douglas Mccord Sammond; Ronald George Sherrill

Bioorganic & Medicinal Chemistry Letters | 2005

Synthesis and antiviral activities of novel N-alkoxy-arylsulfonamide-based HIV protease inhibitors.

Ronald G. Sherrill; Eric S. Furfine; Richard J. Hazen; John F. Miller; David J. Reynolds; Douglas Mccord Sammond; Andrew Spaltenstein; Pat Wheelan; Lois L. Wright

Archive | 2007

DIAMINOPYRIMIDINE UND DEREN VERWENDUNG ALS ANGIOGENESEHEMMER

Stanley D. Chamberlain; Mui Cheung; Holly Kathleen Emerson; Neil W. Johnson; Kristen E. Nailor; Douglas Mccord Sammond; Marcus Semones

Archive | 2005

Nouveaux composes de diazepine utilises comme ligands des recepteurs 1 et/ou 4 de la melanocortine

Jerzy Ryszard Szewczyk; Jason D. Speake; Douglas Mccord Sammond; Ronald George Sherrill

Archive | 2005

Inhibiteurs de la kinase erbb a base de 2-pyrimidinyle pyrazolopyridine

David E. Uehling; Kirk L. Stevens; Scott Howard Dickerson; Alex G. Waterson; Philip A. Harris; Douglas Mccord Sammond; Robert D. Hubbard; Holly Kathleen Emerson; Joseph W. Wilson

Explore More